Clinical Trial Update: Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a combination of myeloid inhibition and radiation to enhance immunotherapy responses in triple-negative breast cancer, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Stephen Shiao | Conditions: TNBC - Triple-Negative Breast Cancer, Breast Cancer | Phase 2 | Status: RECRUITING